Mesoblast is another share placed on pause today.
The post Why is the Mesoblast share price on ice today? appeared first on The Motley Fool Australia. –
The ASX granted the company’s request before market open today. Prior to being put on ice, the Mesoblast share price closed yesterday’s session at 93 cents apiece.
Why is the Mesoblast share price frozen?
It appears the company is gearing up to raise additional capital from equity investors.
In the release, it said it “requests a trading halt in its securities effective immediately pending an announcement…in relation to a proposed private placement.”
It is not yet understood what the capital raise is for, or what amount the company is seeking to raise from investors.
However, it intends to make the impending announcement between now and 8 August, when the trading halt will then be lifted.
Mesoblast shares have caught a bid lately and are now up more than 36% over the past month of trading, as seen in the chart below.
This gain is in line with the broad healthcare sector, which has realized similar levels of upside in the new financial year.
Despite this, the Mesoblast share price is down 54% for the last 12 months or 34% this year to date
Before you consider Mesoblast Limited, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Mesoblast Limited wasn’t one of them.
The online investing service heâs run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
See The 5 Stocks
*Returns as of July 7 2022
setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
Why did the Mesoblast share price rocket 54% in July?
3 ASX All Ordinaries shares leaping 10% or more today
Why JB Hi-Fi, Mesoblast, Pendal, and Woodside shares are pushing higher
Why is the Mesoblast share price jumping 14%?
How did ASX biotech shares perform in FY22?